Mutations in the GALC gene, encoding the glycolipid catabolic enzyme galactocerebrosidase, represent a major genetic risk factor for the onset of MS as they prevent microglia from effectively removing myelin debris, thus hampering myelin regeneration. The gene discussed is GALC; the disease is myeloid sarcoma.